Jentadueto XR (Linagliptin + Metformin Hydrochloride) — Patient Information (Australia)

Jentadueto XR is a combination medicine used for the management of type 2 diabetes. It contains: linagliptin (a DPP-4 inhibitor) and metformin hydrochloride (a biguanide). The “XR” stands for extended-release tablets, designed to release medicine gradually over time.

This page explains what Jentadueto XR does, how it works, how to take it safely, common considerations with food and alcohol, potential side effects, and practical tips for day-to-day use in Australia.

Quick overview

• Medicines in each tablet: Linagliptin + Metformin hydrochloride (extended-release)
• Used for: Improving blood glucose in adults with type 2 diabetes
• Form: XR (extended-release) tablet
• How often: Usually once daily (follow your prescriber’s instructions)
• Key benefits: Helps lower blood sugar while supporting cardiovascular safety profile of DPP-4 inhibitors and improving insulin sensitivity via metformin

What is Jentadueto XR?

Jentadueto XR is an extended-release combination tablet containing: linagliptin and metformin. It helps control blood glucose by combining two complementary approaches:

• Linagliptin: increases incretin hormones (GLP-1 and GIP activity) that reduce blood glucose in a glucose-dependent way.
• Metformin: reduces liver glucose production and improves insulin sensitivity, with a low risk of hypoglycaemia when used alone or with non–hypoglycaemia-causing medicines.

Because the tablets are XR, they are made to release the medicines gradually. This may help with tolerability and convenience compared with immediate-release formulations.

Mechanism of action (how it works)

Linagliptin (DPP-4 inhibitor)

Linagliptin belongs to a class called DPP-4 inhibitors. Incretin hormones (including GLP-1) are released after meals. They help stimulate insulin release and reduce glucagon when blood glucose is elevated. DPP-4 is an enzyme that breaks down incretins. Linagliptin inhibits DPP-4, helping incretin hormones work for longer.

Glucose-dependent effect: Linagliptin generally lowers glucose without driving insulin release when glucose is low, so the risk of hypoglycaemia is relatively low when used without insulin or sulfonylureas.

Metformin (biguanide)

Metformin primarily acts by:

• Reducing hepatic glucose output (less glucose released from the liver)
• Improving insulin sensitivity in peripheral tissues
• Improving glucose uptake and utilisation

Metformin does not typically cause hypoglycaemia by itself, and it is widely used due to its effectiveness and long track record.

Pharmacokinetics (absorption, distribution, and elimination)

“Pharmacokinetics” describes what the body does to the medicine—how it is absorbed, how quickly it reaches peak levels, and how it leaves the body. Individual results vary.

Linagliptin

• Absorption: Absorbed after oral administration; extended-release formulation helps achieve a steady release profile for metformin within the combination tablet.
• Distribution: Linagliptin is highly protein bound.
• Elimination: Predominantly via the hepatobiliary route (with less reliance on kidney clearance compared with some other DPP-4 inhibitors).

Metformin XR

• Absorption: Extended-release metformin is absorbed more gradually than immediate-release formulations.
• Peak effect: The time to reach maximum concentration is typically later with XR tablets.
• Elimination: Mostly excreted via the kidneys. Kidney function is important for safe use.

Because metformin is cleared by the kidneys, dose adjustments or avoidance may be necessary in people with impaired kidney function. Your healthcare professional will base this on your kidney tests.

Typical use and indications

In Australia, Jentadueto XR is used to treat type 2 diabetes in adults. It is typically used:

• As part of combination therapy when blood glucose is not adequately controlled on metformin alone.
• When the benefits of using both a DPP-4 inhibitor and metformin are considered appropriate.

The exact decision to use Jentadueto XR depends on your diabetes history, current medicines, blood glucose measurements (including HbA1c), kidney function, and overall risk profile.

Dosing information (how to take it)

Always follow the dosing instructions on your medicine label or provided by your healthcare professional. The information below is general and may not match your specific tablet strength.

Common dosing pattern

• Most people: Take Jentadueto XR once daily.
• Starting dose: Often begins at a lower strength and is adjusted based on response and tolerability.
• Maintenance dose: May be adjusted to reach desired glucose control.

Missed dose

• If you miss a dose, take it when you remember if there is still time before the next dose.
• If it is close to the next dose, skip the missed dose and continue your usual schedule.
• Do not double the dose to catch up.

Swallowing the XR tablet

XR tablets are designed to release medicine slowly. For safety and effectiveness:

• Swallow whole with water.
• Do not crush, split, or chew unless specifically instructed by your healthcare professional.
• If swallowing tablets is difficult, discuss options with your pharmacist.

Timing: when should you take it?

Jentadueto XR is usually taken once daily. Many people prefer to take it with an evening meal or the meal that best suits their routine.

• Consistency helps: Try to take it around the same time each day.
• If you experience stomach upset: Taking with food may improve tolerability (see food interactions below).

Food interactions and digestion tips

Metformin and most XR products are often better tolerated when taken with food. Food can reduce gastrointestinal side effects such as nausea, stomach discomfort, or diarrhoea.

• Take with or after meals: Many people are advised to take Jentadueto XR with food.
• Avoid sudden diet extremes: Very low-calorie diets or prolonged fasting may increase the risk of dehydration and other complications.
• Hydration matters: Drink adequate fluids—especially if you are unwell.

There are no special “forbidden foods” for Jentadueto XR. However, carbohydrate intake and overall diet quality remain central to diabetes control.

Alcohol and medicine interactions

Alcohol

Alcohol can affect blood glucose and may increase risk of adverse effects with metformin, particularly when intake is heavy or when combined with dehydration. For safety:

• Avoid binge drinking.
• If you drink alcohol, do so in moderation and usually with food.
• Be extra careful if you are unwell, have vomiting/diarrhoea, or are not eating normally.

People with conditions that increase lactic acid risk (for example, severe kidney impairment, severe liver disease, or significant tissue hypoxia) should discuss alcohol use with a clinician.

Interactions with other medicines

Drug interactions can be complex. Some medicines can affect blood glucose, kidney function, or the way metformin is handled. Always tell your pharmacist or doctor about all medicines and supplements you use, including over-the-counter products.

Common interaction themes:

• Kidney function changes: Dehydrating medicines (such as certain diuretics) or illnesses that reduce kidney function can increase metformin risk.
• Contrast dye for imaging: Some radiology procedures using iodine-based contrast may require temporary management of metformin—ask the radiology team or your doctor.
• Blood sugar-lowering medicines: If used alongside insulin or sulfonylureas, the overall risk of hypoglycaemia may increase.

Safety profile and side effects

Most people tolerate Jentadueto XR well, but side effects can occur. The key is recognising what is common versus what needs urgent attention.

Common side effects

• Gastrointestinal symptoms: diarrhoea, nausea, indigestion, abdominal discomfort, flatulence
• Reduced appetite

Gastrointestinal side effects are often more noticeable at the beginning and may improve with time, taking the tablet with meals, and following the prescribed dose escalation plan.

Hypoglycaemia risk

Linagliptin and metformin generally have a low risk of hypoglycaemia when used without insulin or sulfonylureas. However, if you take other diabetes medicines that can cause low blood sugar, symptoms may still occur.

Possible hypoglycaemia symptoms include:

• Shaking, sweating
• Fast heartbeat
• Dizziness, hunger, headache
• Confusion, weakness

Seek urgent medical help if you notice

Although uncommon, the following situations require prompt assessment:

• Signs of severe allergic reaction: swelling of face/lips, difficulty breathing, widespread rash
• Lactic acidosis warning signs (a rare but serious complication associated with metformin): unusual muscle pain, severe tiredness, trouble breathing, stomach pain with vomiting, feeling cold or dizzy, or irregular heartbeat.
• Severe dehydration from vomiting/diarrhoea or inability to eat/drink

Risk of lactic acidosis increases in certain settings such as kidney impairment, severe infection, dehydration, or low oxygen states. If you become very unwell, contact a clinician for advice.

Important precautions

• Kidney function: Metformin is cleared by the kidneys, so your doctor may check kidney function periodically.
• Liver disease: Discuss any significant liver problems.
• Heart failure or poor circulation: Inform your healthcare team.
• Before certain procedures: Imaging with contrast may affect metformin management.

Practical use tips (getting the best results)

• Take it consistently: Aim for the same time each day to maintain stable blood levels.
• Take with food if advised: This can improve tolerability for metformin.
• Keep tablets intact: XR tablets should be swallowed whole.
• Monitor your glucose: Your healthcare professional may recommend home glucose monitoring or periodic HbA1c testing.
• Stay hydrated: Especially during hot weather, illness, or increased physical activity.
• Know your “sick day plan”: If you vomit, have diarrhoea, cannot eat, or are dehydrated, seek advice. Metformin may need temporary review.

Alternative options (what else may be considered)

Diabetes medicines vary by person. Depending on your health profile and treatment goals, a clinician may consider other options, such as:

Other metformin formulations

• Immediate-release metformin or different XR strengths
• Sometimes dose adjustment is used to improve tolerance

Other incretin-based options

• Other DPP-4 inhibitors (such as sitagliptin, saxagliptin, vildagliptin—depending on availability and suitability)
• GLP-1 receptor agonists or dual GIP/GLP-1 therapies in appropriate patients (these can involve injection or specific formulations)

Other glucose-lowering medicine classes

• SGLT2 inhibitors (may be beneficial in selected patients, particularly for kidney/heart risk considerations)
• Sulfonylureas (effective but can increase hypoglycaemia risk)
• Insulin (used when needed for glycaemic control)

Your best alternative depends on your kidney function, cardiovascular risk, weight considerations, and risk of hypoglycaemia. Discuss options with your healthcare professional.

Australia market and legal context (high-level)

In Australia, diabetes medicines including combination therapies such as Jentadueto XR are regulated under the Australian Therapeutic Goods Administration (TGA). Medicines are required to meet quality, safety, and efficacy standards, and are supplied through the health system according to local prescribing and distribution rules.

Availability, tablet strengths, and eligibility for reimbursement can vary based on pharmaceutical benefit arrangements and individual circumstances. Online pharmacy services typically provide general information and help coordinate ordering and delivery within Australian regulations.

Recent guidance and clinical considerations

Diabetes care guidance in Australia is shaped by updates in clinical practice and evolving evidence. Clinicians often consider:

• Individualised treatment goals based on HbA1c and overall health
• Cardiovascular and renal risk when selecting glucose-lowering therapies
• Minimising hypoglycaemia risk where possible
• Ongoing medication review to ensure benefits outweigh harms over time
• Kidney function monitoring for medicines containing metformin

Your healthcare provider may adjust therapy as new evidence emerges, as your HbA1c changes, or as your kidney function or other health factors evolve.

Delivery and availability

Jentadueto XR availability can vary by strength and formulation. Online pharmacies may offer delivery across Australia, depending on stock levels and courier services.

• Check stock for your tablet strength: XR combinations come in different strengths.
• Delivery timeframes: Often depend on your location (metro vs regional) and confirmation of order fulfilment.
• Packaging: Medicines are typically supplied in tamper-evident packaging.

If you have not used Jentadueto XR before, consider confirming the exact strength on your label before you start.

Storage information

• Store at room temperature unless your label specifies otherwise.
• Keep tablets in their original packaging to protect them from moisture.
• Keep out of the reach of children.

FAQ (Frequently asked questions)

1) What is Jentadueto XR used for?

It is used to improve blood glucose control in adults with type 2 diabetes, commonly when metformin alone is not enough or a combination approach is appropriate.

2) How quickly does it work?

Many people see improvements in blood glucose within days to weeks. The full effect is usually evaluated over time using HbA1c testing and ongoing glucose readings.

3) Can I take Jentadueto XR with food?

Often yes, and taking it with meals may help reduce metformin-related stomach side effects. Follow your label directions and your healthcare professional’s advice.

4) What if I forget a dose?

Take it when you remember if it’s not too close to the next dose. Otherwise, skip and continue your usual routine. Do not double the dose.

5) Does Jentadueto XR cause weight gain?

Metformin is generally weight-neutral or may lead to modest weight stability. Linagliptin is also generally weight-neutral. Individual responses vary.

6) Can I drink alcohol while using Jentadueto XR?

Moderate alcohol may be possible for some people, but avoid binge drinking. Alcohol can increase the risk of low blood sugar and may increase metformin-related risks in certain situations, especially if you are dehydrated or unwell.

7) Is hypoglycaemia possible?

Hypoglycaemia is less common with metformin and linagliptin than with insulin or sulfonylureas. However, it can still occur if combined with other glucose-lowering medicines.

8) What are the main side effects to watch for?

Common ones include nausea, diarrhoea, and abdominal discomfort. Seek urgent medical help for signs of severe allergic reaction or possible lactic acidosis (rare but serious).

9) Who should be extra careful with this medicine?

People with reduced kidney function, significant illness causing dehydration, or conditions that increase lactic acid risk should use metformin with extra caution and close monitoring.

10) Are there alternatives to Jentadueto XR?

Yes. Options may include metformin alone, other combinations, different incretin therapies, SGLT2 inhibitors, or other diabetes medicines depending on your health profile. Your clinician can help choose the best fit.

Summary

Jentadueto XR combines linagliptin and metformin extended-release to help control blood glucose in adults with type 2 diabetes. It works by enhancing incretin activity (linagliptin) and improving insulin sensitivity and reducing liver glucose output (metformin). When taken once daily and used alongside healthy eating, physical activity, and regular monitoring, it can be an effective long-term option for many people.